Title
Resolution Approving the City of Hampton’s Participation in the Proposed Settlements of Opioid-Related Claims Against, Associated Pharmacies, Inc. (and American Associated Pharmacies); J M Smith Corporation; Louisiana Wholesale Drug Company, Inc.; Morris and Dickson Co.; North Carolina Mutual Wholesale Drug Company, Inc.; and United Natural Foods, Inc. (including its subsidiaries SuperValu and Advantage Logistics), and Directing the City Manager to Execute the Documents Necessary to Effectuate the City of Hampton’s Participation in the Settlements
Purpose
PURPOSE/BACKGROUND:
On November 10, 2021, the City Council approved the City's participation in a Memorandum of Understanding governing the statewide distribution of settlement funds relating to ongoing litigation by the state with several companies involved in the manufacture and distribution of opioids. At the time, the only settlements which had been reached were with distributors McKesson, Cardinal Health and AmerisourceBergen, and manufacturer Janssen Pharmaceuticals. On March 8, 2023, City Council approved additional settlements with manufacturers Teva, Allergan, and retailers Walmart, Walgreens and CVS. On July 10, 2024, City Council approved an additional settlement with Kroger and its related corporate entities. On August 13, 2025, City Council approved an additional settlement with against the Sackler Family, and on September 10, 2025, City Council approved an additional settlement with opioid manufacturers Alyogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus. Settlements have now been reached with six regional pharmacies: Associated Pharmacies, Inc. (and American Associated Pharmacies); J M Smith Corporation; Louisiana Wholesale Drug Company, Inc.; Morris and Dickson Co.; North Carolina Mutual Wholesale Drug Company, Inc.; and United Natural Foods, Inc. (including its subsidiaries SuperValu and Advantage Logistics). This resolution would approve the City's participation in ...
Click here for full text